Gene therapy company with operations in KoP files for $100M IPO

The company has raised about $265 million, including $148 million in a Series C round disclosed last month.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 19, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news